320 related articles for article (PubMed ID: 16775449)
1. The metabolic syndrome and chronic kidney disease.
Peralta CA; Kurella M; Lo JC; Chertow GM
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
[TBL] [Abstract][Full Text] [Related]
2. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
Beddhu S; Kimmel PL; Ramkumar N; Cheung AK
Am J Kidney Dis; 2005 Oct; 46(4):577-86. PubMed ID: 16183411
[TBL] [Abstract][Full Text] [Related]
3. Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
Chen J; Gu D; Chen CS; Wu X; Hamm LL; Muntner P; Batuman V; Lee CH; Whelton PK; He J
Nephrol Dial Transplant; 2007 Apr; 22(4):1100-6. PubMed ID: 17272313
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
[TBL] [Abstract][Full Text] [Related]
5. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
Sarafidis PA
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study.
Watanabe H; Obata H; Watanabe T; Sasaki S; Nagai K; Aizawa Y
Diabetes Metab Res Rev; 2010 Jan; 26(1):26-32. PubMed ID: 20014332
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and chronic kidney disease.
Guarnieri G; Zanetti M; Vinci P; Cattin MR; Pirulli A; Barazzoni R
J Ren Nutr; 2010 Sep; 20(5 Suppl):S19-23. PubMed ID: 20797564
[TBL] [Abstract][Full Text] [Related]
8. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
[TBL] [Abstract][Full Text] [Related]
10. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
[TBL] [Abstract][Full Text] [Related]
11. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
Wahba IM; Mak RH
Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
[TBL] [Abstract][Full Text] [Related]
12. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
[TBL] [Abstract][Full Text] [Related]
13. Renal manifestations in the metabolic syndrome.
Locatelli F; Pozzoni P; Del Vecchio L
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome: at the crossroads of cardiorenal risk.
Natali A; Pucci G; Boldrini B; Schillaci G
J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
16. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.
Rao MV; Qiu Y; Wang C; Bakris G
Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S30-7. PubMed ID: 18359406
[TBL] [Abstract][Full Text] [Related]
17. Renal disease, the metabolic syndrome, and cardiovascular disease.
Hoy WE; Kondalsamy-Chennakesavan S; McDonald S; Wang Z
Ethn Dis; 2006; 16(2 Suppl 2):S2-46-51. PubMed ID: 16774010
[TBL] [Abstract][Full Text] [Related]
18. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
Zarich SW
Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
